Whole exome sequencing of fetal structural anomalies detected by ultrasonography
- PMID: 33144663
- DOI: 10.1038/s10038-020-00869-8
Whole exome sequencing of fetal structural anomalies detected by ultrasonography
Abstract
The objective of this study was to evaluate the efficacy of whole exome sequencing (WES) for the genetic diagnosis of cases presenting with fetal structural anomalies detected by ultrasonography. WES was performed on 19 cases with prenatal structural anomalies. Genomic DNA was extracted from umbilical cords or umbilical blood obtained shortly after birth. WES data were analyzed on prenatal phenotypes alone, and the data were re-analyzed after information regarding the postnatal phenotype was obtained. Based solely on the fetal phenotype, pathogenic, or likely pathogenic, single nucleotide variants were identified in 5 of 19 (26.3%) cases. Moreover, we detected trisomy 21 in two cases by WES-based copy number variation analysis. The overall diagnostic rate was 36.8% (7/19). They were all compatible with respective fetal structural anomalies. By referring to postnatal phenotype information, another candidate variant was identified by a postnatal clinical feature that was not detected in prenatal screening. As detailed phenotyping is desirable for better diagnostic rates in WES analysis, we should be aware that fetal phenotype is a useful, but sometimes limited source of information for comprehensive genetic analysis. It is important to amass more data of genotype-phenotype correlations, especially to appropriately assess the validity of WES in prenatal settings.
References
-
- Normand EA, Braxton A, Nassef S, Ward PA, Vetrini F, He W, et al. Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder. Genome Med. 2018;10:74. - DOI
-
- Alamillo CL, Powis Z, Farwell K, Shahmirzadi L, Weltmer EC, Turocy J, et al. Exome sequencing positively identified relevant alterations in more than half of cases with an indication of prenatal ultrasound anomalies. Prenat Diagnosis. 2015;35:1073–8. - DOI
-
- Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367:2175–84. - DOI
-
- Petrovski S, Aggarwal V, Giordano JL, Stosic M, Wou K, Bier L, et al. Whole-exome sequencing in the evaluation of fetal structural anomalies: a prospective cohort study. Lancet (Lond, Engl). 2019;393:758–67. - DOI
-
- Best S, Wou K, Vora N, Van der Veyver IB, Wapner R, et al. Promises, pitfalls and practicalities of prenatal whole exome sequencing. Prenat Diagnosis. 2018;38:10–19. - DOI
Publication types
MeSH terms
Substances
Grants and funding
- JP19ek0109280, JP19dm0107090, JP19ek0109301, JP19ek0109348, JP19kk0205001/Japan Agency for Medical Research and Development (AMED)
- JP17H01539, JP16H05357, JP16H06254, JP17K16132, JP17K10080, JP17K15630, JP17H06994/Japan Society for the Promotion of Science London (JSPS London)
- 30-6, 30-7/Ministry of Health, Labour and Welfare (Ministry of Health, Labour and Welfare, Japan)
LinkOut - more resources
Medical
Research Materials